KLK3 and prostate adenocarcinoma: Moreover, the anticancer activity of these proionophores was investigated in androgen-sensitive human prostate adenocarcinoma cells (LNCaP), which express PSA, and androgen-independent PC3 cell lines that do not express PSA (Tai et al., 2011).